Oscar Health, Inc.
OSCRNYSECIK 1568651FinancialsFiscal year ends Dec 31
Reports and events: 99 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-09-1800:18 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001193125-26-395843 |
| 2026-09-1610:02 ET | 8-K | 7.01 Regulation FD disclosure | 0001568651-26-000074 |
| 2026-08-0721:39 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001568651-26-000069 |
| 2026-08-0610:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001568651-26-000066 |
| 2026-06-0920:11 ET | 8-K | 5.07 Shareholder vote results | 0001568651-26-000059 |
| 2026-06-0810:29 ET | 8-K | 7.01 Regulation FD disclosure | 0001568651-26-000054 |
| 2026-06-0210:31 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001568651-26-000048 |
| 2026-05-0720:24 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001568651-26-000040 |
| 2026-05-0610:19 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001568651-26-000036 |
| 2026-04-2220:16 ET | DEF 14A | Proxy statementPeriod 2026-06-04 | 0001140361-26-016119 |
| 2026-04-2110:56 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001568651-26-000028 |
| 2026-03-0211:41 ET | 8-K | 7.01 Regulation FD disclosure | 0001568651-26-000014 |
| 2026-02-1321:27 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001568651-26-000011 |
| 2026-02-1011:25 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001568651-26-000008 |
| 2025-12-2921:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-25-335294 |
| 2025-11-0621:35 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001568651-25-000037 |
| 2025-11-0611:10 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001568651-25-000035 |
| 2025-09-1820:15 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-25-207417 |
| 2025-09-1610:10 ET | 8-K | 1.02 Termination of a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-204231 |
| 2025-09-1520:07 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-203549 |
| 2025-09-0310:30 ET | 8-K | 7.01 Regulation FD disclosure | 0001193125-25-194448 |
| 2025-08-0720:13 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001568651-25-000025 |
| 2025-08-0610:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001568651-25-000021 |
| 2025-07-2210:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001568651-25-000018 |
| 2025-06-0620:05 ET | 8-K | 5.07 Shareholder vote results | 0001193125-25-137039 |
| 2025-05-0823:11 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001568651-25-000015 |
| 2025-05-0710:24 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001568651-25-000012 |
| 2025-04-2512:00 ET | DEF 14A | Proxy statementPeriod 2025-06-04 | 0001140361-25-015601 |
| 2025-03-0311:46 ET | 8-K | 7.01 Regulation FD disclosure | 0001193125-25-043364 |
| 2025-02-2021:06 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001568651-25-000008 |
| 2025-02-0421:07 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001568651-25-000005 |
| 2024-11-1302:24 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-24-257647 |
| 2024-11-0721:11 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001568651-24-000032 |
| 2024-11-0711:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001568651-24-000029 |
| 2024-09-0410:30 ET | 8-K | 7.01 Regulation FD disclosure | 0001193125-24-212607 |
| 2024-08-0720:10 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001568651-24-000023 |
| 2024-08-0710:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001568651-24-000021 |
| 2024-06-1120:16 ET | 8-K | 5.07 Shareholder vote results | 0001193125-24-159132 |
| 2024-06-0710:01 ET | 8-K | 7.01 Regulation FD disclosure | 0001193125-24-156438 |
| 2024-05-0720:18 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001568651-24-000015 |
| 2024-05-0710:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001568651-24-000013 |
| 2024-04-2512:12 ET | DEF 14A | Proxy statementPeriod 2024-06-06 | 0001140361-24-021911 |
| 2024-02-1521:06 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001568651-24-000006 |
| 2024-02-0721:13 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001568651-24-000004 |
| 2024-01-1011:07 ET | 8-K | 2.02 Results of operations | 0001193125-24-005574 |
| 2023-12-2911:04 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-23-305664 |
| 2023-11-2011:18 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-23-280184 |
| 2023-11-0721:17 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001568651-23-000056 |
| 2023-11-0711:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001568651-23-000054 |
| 2023-09-1110:06 ET | 8-K | 7.01 Regulation FD disclosure | 0001193125-23-231903 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:13 ET. Listed shows no prices and gives no investment advice.